Pediatric stroke: What do we know and what do we need to know?

被引:52
|
作者
Lynch, JK [1 ]
Han, CJ [1 ]
机构
[1] NINDS, Neuroepidemiol Branch, Bethesda, MD 20892 USA
关键词
cerebrovascular diseases; child;
D O I
10.1055/s-2005-923535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Stroke is a heterogeneous disorder and an important cause of mortality and chronic morbidity in children. Estimates of international incidence rates for childhood stroke have varied widely. Arterial ischemic stroke is reported to be more common than hemorrhagic stroke in children. The clinical presentation of stroke in children differs according to the child's age and stroke type and location. Several risk factors for ischemic and hemorrhagic stroke in children have been reported and include cardiac disorders, blood disorders, vasculopathies, viral infections, and arteriovenous malformations. Current treatment recommendations for stroke in children are based on small nonrandomized trials, adult stroke studies, case series, or consensus or individual expert opinion. Over half of children with stroke will develop lifelong cognitive or motor disability, and up to a third will have a recurrent stroke. International studies have provided important information on stroke in children, but major gaps in our knowledge of the disorder still exist. Currently, there is a need for prospective cohort studies in diverse populations, which utilize a consensus pediatric stroke classification system and a standard evaluation of risk factors and outcome, so that treatment and prevention strategies can be developed.
引用
收藏
页码:410 / 423
页数:14
相关论文
共 50 条
  • [11] Food OIT What do we know, what don't we know, and what do we need to know?
    Ciaccio, Christina E.
    Bauer, Maureen Egan
    Nowak-Wegrzyn, Anna
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (02) : 118 - 119
  • [12] Measurement Bias in the HICP: What do we know and what do we need to know?
    Wynne, MA
    Rodriguez-Palenzuela, D
    [J]. JOURNAL OF ECONOMIC SURVEYS, 2004, 18 (01) : 79 - 112
  • [13] Health Inequalities: What do we know and what do we need to know? Introduction
    Olafsdottir, Sigrun
    Beckfield, Jason
    [J]. SOCIAL SCIENCE & MEDICINE, 2020, 267
  • [14] The Tradeoffs of Inclusionary Zoning: What Do We Know and What Do We Need to Know?
    Mukhija, Vinit
    Das, Ashok
    Regus, Lara
    Tsay, Sara Slovin
    [J]. PLANNING PRACTICE AND RESEARCH, 2015, 30 (02): : 222 - 235
  • [15] Translating and Revising for Localisation: What do We Know? What do We Need to Know?
    Garcia, Ignacio
    [J]. PERSPECTIVES-STUDIES IN TRANSLATION THEORY AND PRACTICE, 2008, 16 (1-2): : 49 - 60
  • [16] Mycotoxins and mycotoxicosis in Tunisia: What do we know and what do we need to know?
    Bacha, H
    Maaroufi, K
    Ghedira-Chekir, L
    Abid, S
    Cherif, A
    Achour, A
    Creppy, EE
    [J]. JOURNAL OF TOXICOLOGY-TOXIN REVIEWS, 1999, 18 (3-4): : 245 - 262
  • [17] Prone position in ARDS: What do we know, and what do we need to know?
    Albert, RK
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (11) : 2574 - 2575
  • [18] The problem with prostatitis. What do we know? What do we need to know?
    Krieger, JN
    [J]. JOURNAL OF UROLOGY, 2004, 172 (02): : 432 - 433
  • [19] STEPFAMILIES - WHAT DO WE KNOW - WHAT DO WE NEED TO KNOW - DEATH,E
    SLIPMAN, S
    [J]. BRITISH JOURNAL OF EDUCATIONAL PSYCHOLOGY, 1993, 63 : 364 - 365
  • [20] Cerebrovascular diseases in Nigeria: what do we know and what do we need to know?
    Ogungbo, BI
    Gregson, B
    Mendelow, AD
    Walker, R
    [J]. TROPICAL DOCTOR, 2003, 33 (01) : 25 - 30